Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer
Go back to Nuvig Therapeutics Appoints Julie Smith Chief Executive Officer| Exelixis, Inc. (NASDAQ: EXEL) | Delayed: 54.08 +0.39 (0.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.69 | 52 Week High | $17.00 | |||
| Open | $53.74 | 52 Week Low | $3.55 | |||
| Day High | $54.68 | P/E | N/A | |||
| Day Low | $53.70 | EPS | $-1.33 | |||
| Volume | 1,949,759 | |||||
| (NASDAQ: STOK) | Delayed: 32.29 +0.89 (2.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.40 | 52 Week High | $ | |||
| Open | $31.76 | 52 Week Low | $ | |||
| Day High | $32.77 | P/E | N/A | |||
| Day Low | $31.52 | EPS | $ | |||
| Volume | 1,274,423 | |||||

